Press release from Companies
Publicerat: 2022-03-09 08:40:08
Copenhagen, Denmark, 9 March 2022 - Curasight A/S ("Curasight" or the "Company") announces that the Company’s Annual General Meeting will be held on 27 April 2022 and an updated financial calendar for rest of 2022
The Annual General Meeting of Curasight is planned to be held on 27 April 2022. Consequently, the financial calendar and information on the date of the Annual General Meeting set out in the Annual Report for the financial year 2021 are updated accordingly. Curasight has thus scheduled the following dates for the remainder of 2022: Deadline for submission of shareholder proposals to Annual General Meeting Annual General Meeting 2022 Interim Report Q1 2022 Interim Report First Half 2022 Interim Report Q3 2022 For more information regarding Curasight, please contact: Ulrich Krasilnikoff, CEO Phone: +45 22 83 01 60 E-mail: uk@curasight.com Curasight is a clinical development company based in Copenhagen, Denmark. The company is a pioneer in the field of exploiting a novel theranostic platform with Positron Emissions Tomography (PET) imaging and Radionuclide Therapy targeting the urokinase-type plasminogen activator receptor ("uPAR"). The technology is expected to improve diagnosis, risk stratification and therapy in multiple cancer types.
March 15, 2022
April 27, 2022
May 24, 2022
August 25, 2022
November 24, 2022
